Preliminary classification of nonmalignant B cell proliferation in Sjogren's syndrome: Perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach
Preliminary classification of nonmalignant B cell proliferation in Sjogren's syndrome: Perspectives on pathobiology and treatment based on an integrated clinico-pathologic and molecular study approach
复制标题
DOI:
10.1006/bcmd.2001.0446
复制
发表时间:
2001-07-01
影响因子:
2.3
通讯作者:
Ferraccioli, G
中科院分区:
文献类型:
--
作者:
De Vita, S;De Marchi, G;Ferraccioli, G
A classification of nonmalignant lymphoproliferation in Sjogren's syndrome is presented, based on the results of international meetings regarding Sjogren's syndrome-associated lymphomagenesis and on our results of a clinico-pathologic and molecular study and long-term follow-up in well-characterized patients. Sjogren's syndrome pathobiology has similarities to hepatitis C virus-related B-cell lymphoproliferation. Antigen stimulation with the preferential expansion of rheumatoid factor-positive clones and specific immunoglobulin gene expression and recombination represent key biologic events in lymphoproliferation. This classification is based on the coupling of molecular and histological studies and may result in more selective treatment approaches. (C) 2001 Academic Press.